Is This Healthcare Stock Set To Rally?
Eli Lilly has been a frustrating hold so far this year. Shares are slightly down year to date, a rare stumble for a company that has delivered nearly 5x returns over the past five years.
For a stock that’s become a poster child of the weight-loss and diabetes boom, the slowdown in momentum has left investors wondering if the story has run its course.
» Read more about: Is This Healthcare Stock Set To Rally? »
Read More
Cava’s Dip Looks Tasty, Why This Sell-Off Could Be a Gift
Cava Group has done what its customers do best: dip. After hitting an all-time high near $172 last November, the shares have slid to the high-$60s, roughly a 60% slide from the peak, even though the business keeps putting up solid numbers.
That kind of disconnect tends to create opportunity for patient investors who care more about unit economics than headlines.
» Read more about: Cava’s Dip Looks Tasty, Why This Sell-Off Could Be a Gift »
Read More
Buffett’s $19 Billion Oil Bet Looks Like a Fortress
It’s the rare oil major that seems built to outlast cycles, keep the dividend flowing, and, as Warren Buffett clearly believes, keep getting stronger.
The yield is about 4.4%, nearly four times what the S&P 500 pays and on paper that looks tempting, but high yields in energy can be a trap. The difference here is Chevron’s payout isn’t balanced on a knife’s edge.
» Read more about: Buffett’s $19 Billion Oil Bet Looks Like a Fortress »
Read More
From Market Darling to Punchline and Back Again?
Every few years, investors rediscover Plug Power (NASDAQ: PLUG) and wonder if the long-suffering hydrogen pioneer is finally about to turn the corner. Today, it’s officially a penny stock, which means under $5 per share technically.
And that’s a painful reminder that, adjusted for reverse splits, Plug’s pre-dot com IPO price of $150 feels almost mythical compared to where the stock sits today.
» Read more about: From Market Darling to Punchline and Back Again? »
Read More
Is AppLovin Still a Buy After Its Incredible Run?
AppLovin (NASDAQ: APP) has had the kind of year investors dream about. The mobile app marketing and advertising platform, best known for its strength in mobile gaming has seen its stock rocket more than 5x over the past 12 months, fueled by relentless revenue growth and eye-popping profits.
With a move that big,
» Read more about: Is AppLovin Still a Buy After Its Incredible Run? »
Read MoreThe Burst
Could Alphabet Become the World’s Largest Company
Alphabet (NASDAQ: GOOGL) is already a giant, but it may still be in the early innings of its growth story. With a market capitalization hovering just shy of $3 trillion, it is within striking distance of becoming the world’s next $4 trillion stock.
What makes this more than just speculation is that several potential roadblocks have recently cleared,
» Read more about: Could Alphabet Become the World’s Largest Company »
Read MoreThe Spotlight
Buffett Would Love This Moat, Freeport’s Hidden Growth Engine
In the short run, tariff headlines can turn Mr. Market into a nervous wreck. In the long run, owners do fine by owning scarce, low-cost assets run by rational people. Freeport-McMoRan fits that bill.
U.S. copper prices sold off after Washington excluded refined copper from its new 50% tariffs and instead targeted semi-finished products like wire,
» Read more about: Buffett Would Love This Moat, Freeport’s Hidden Growth Engine »
Read MoreThe Daily
Cerulli, DCALTA study challenges misconceptions on private markets in 401(k) plans
Criticisms around risky exposures, illiquidity, litigation threats, and unsuitability are substantially off the mark, report says.
A new joint study from Cerulli Associates and the Defined Contribution Alternatives Association is challenging long-held assumptions about the role of private-market investments in 401(k) plans, as industry participants seek to broaden the investment universe for American retirement savers.